伊藤 泰平

Medicine & Life Sciences

1. Pancreas Transplantation 100%
2. Kidney Transplantation 72%
3. Tissue Donors 62%
4. Islets of Langerhans Transplantation 49%
5. Pancreas 44%
6. Brain Death 42%
7. Transplants 40%
8. Japan 38%
9. Transplantation 36%
10. Living Donors 34%
11. Graft Survival 22%
12. Kidney 20%
13. Transplant Recipients 18%
14. dicarboxydine 16%
15. Glucagon 16%
16. Insulin 15%
17. Type 1 Diabetes Mellitus 13%
18. Positron-Emission Tomography 12%
19. Mesenchymal Stem Cells 12%
20. Chimerism 11%
21. C-Peptide 10%
22. mesobiliverdin 10%
23. Pancreatectomy 10%
24. Tissue and Organ Procurement 9%
25. Survival Rate 9%
26. Methionine 9%
27. Registries 9%
28. Propensity Score 8%
29. Laser Scanning Cytometry 8%
30. Islets of Langerhans 8%
31. Mycophenolic Acid 7%
32. Sonazoid 7%
33. Organ Transplantation 7%
34. Digestive System Neoplasms 7%
35. Herpes Zoster Oticus 7%
36. Glucose Tolerance Test 7%
37. Polyomavirus Infections 7%
38. Graft vs Host Disease 7%
39. Liver 7%
40. Ultrasonography 7%
41. Delayed Graft Function 6%
42. Warm Ischemia 6%
43. Posterior Leukoencephalopathy Syndrome 6%
44. BK Virus 6%
45. Nephrectomy 6%
46. Basiliximab 6%
47. Transplantation Tolerance 6%
48. Allografts 5%
49. Chronic Kidney Failure 5%
50. Splenic Vein 5%